High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: A prospective cohort study

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Huttunen, Reetta ^a,b   Hurme, Mikko ^b,c   Aittoniemi, Janne ^c   Huhtala, Heini ^d   Vuento, Risto ^c   Laine, Janne ^a   Jylhävä, Juulia ^b   Syrjänen, Jaana ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PENTRAXIN 3; SERUM AMYLOID P;

ADULT; AGED; ARTICLE; BACTEREMIA; BETA HEMOLYTIC STREPTOCOCCUS; BLOOD CULTURE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FATALITY; FEMALE; HUMAN; HYPOTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ADOLESCENT; BLOOD; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME;

ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SERUM AMYLOID P-COMPONENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952516148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017653     Document Type: Article

References (22)

1. Brun-Buisson C, Doyon F, Carlet J, (1996) Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 154: 617-24.
2. Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, et al. (2009) Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35: 909-13.
3. Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, et al. (2009) The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 227: 9-18.
4. Mantovani A, Garlanda C, Doni A, Bottazzi B, (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28: 1-13.
5. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, et al. (2002) Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 420: 182-6.
6. Garlanda C, Bottazzi B, Bastone A, Mantovani A, (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23: 337-66.
7. Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, et al. (2010) Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 36: 621-9.
8. Sprong T, Peri G, Neeleman C, Mantovani A, Signorini S, et al. (2009) Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock 31: 28-32.
9. Mairuhu AT, Peri G, Setiati TE, Hack CE, Koraka P, et al. (2005) Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 76: 547-52.
10. Wagenaar JF, Goris MG, Gasem MH, Isbandrio B, Moalli F, et al. (2009) Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect 58: 425-32.
11. Muller B, Peri G, Doni A, Torri V, Landmann R, et al. (2001) Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 29: 1404-7.
12. de Kruif MD, Limper M, Sierhuis K, Wagenaar JF, Spek CA, et al. (2010) PTX3 predicts severe disease in febrile patients at the emergency department. J Infect 60: 122-7.
13. Mauri T, Coppadoro A, Bellani G, Bombino M, Patroniti N, et al. (2008) Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit Care Med 36: 2302-8.
14. He X, Han B, Liu M, (2007) Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol 292: L1039-49.
15. Huttunen R, Laine J, Lumio J, Vuento R, Syrjänen J, (2007) Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia. BMC Infect Dis 7: 13.
16. McCabe WR, (1962) Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 110: 856-864.
17. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, et al. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-10.
18. Boyd JC, (1997) Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scand J Clin Lab Invest (Suppl 227): 46-63.
19. Dias AA, Goodman AR, Dos Santos JL, Gomes RN, Altmeyer A, et al. (2001) TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. J Leukoc Biol 69: 928-36.
20. Soares AC, Souza DG, Pinho V, Vieira AT, Nicoli JR, et al. (2006) Dual function of the long pentraxin PTX3 in resistance against pulmonary infection with Klebsiella pneumoniae in transgenic mice. Microbes Infect 8: 1321-9.
21. Marshall JC, Reinhart K, (2009) Biomarkers of sepsis. Crit Care Med 37: 2290-8.
22. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED, (2006) Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 10: R60.